Randomised double-blind comparison of hand-held inhalers versus electric compressors and nebulisers, for domiciliary high-dose bronchodilator treatment in severe stable chronic obstructive pulmonary disease (COPD).

http://isrctn.org/> ◽

10.1186/isrctn36776916 ◽

2013 ◽

Author(s):

Kate Hill

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Chronic Obstructive ◽

High Dose ◽

Double Blind ◽

Obstructive Pulmonary Disease ◽

Bronchodilator Treatment ◽

Blind Comparison

Download Full-text

Faculty of 1000 evaluation for High-Dose N-Acetylcysteine in Stable Chronic Obstructive Pulmonary Disease: the 1-Year, Double-Blind, Randomized, Placebo-Controlled HIACE Study.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.717976481.793471446 ◽

2013 ◽

Author(s):

Shawn Aaron

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Chronic Obstructive ◽

High Dose ◽

Double Blind ◽

Obstructive Pulmonary Disease

Download Full-text

Faculty Opinions recommendation of Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718313352.793493922 ◽

2014 ◽

Author(s):

Mark Dransfield ◽

Michael Wells ◽

Surya Bhatt

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Controlled Trial ◽

Chronic Obstructive ◽

Double Blind ◽

Obstructive Pulmonary Disease ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of Tadalafil in patients with chronic obstructive pulmonary disease: a randomised, double-blind, parallel-group, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718348198.793494105 ◽

2014 ◽

Author(s):

Adam Wanner ◽

Timothy Scialla

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Controlled Trial ◽

Chronic Obstructive ◽

Double Blind ◽

Obstructive Pulmonary Disease ◽

Download Full-text

Sugarcane bagasse dietary fiber as an adjuvant therapy for stable chronic obstructive pulmonary disease: a four-center, randomized, double-blind, placebo-controlled study

Journal of Traditional Chinese Medicine ◽

10.1016/s0254-6272(16)30057-7 ◽

2016 ◽

Vol 36 (4) ◽

pp. 418-426 ◽

Author(s):

Liu Miao ◽

Zheng Fengjie ◽

Ni Lei ◽

Sun Yan ◽

Wu Ruohan ◽

...

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Adjuvant Therapy ◽

Dietary Fiber ◽

Pulmonary Disease ◽

Sugarcane Bagasse ◽

Controlled Study ◽

Chronic Obstructive ◽

Double Blind ◽

Obstructive Pulmonary Disease ◽

Double Blind Placebo

Download Full-text

Supplemental dietary nitrate for chronic obstructive pulmonary disease: a randomized, double-blind, placebo-controlled, crossover trial

Proceedings of The Nutrition Society ◽

10.1017/s0029665113001705 ◽

2013 ◽

Vol 72 (OCE3) ◽

Author(s):

C. P. Kerley ◽

K. Cahill ◽

K. Bolger ◽

K. Fennell ◽

A. O'Brien ◽

...

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Crossover Trial ◽

Chronic Obstructive ◽

Double Blind ◽

Obstructive Pulmonary Disease ◽

Dietary Nitrate ◽

Double Blind Placebo

Download Full-text

Efficacy and safety of the p38 MAPK inhibitor losmapimod for patients with chronic obstructive pulmonary disease: a randomised, double-blind, placebo-controlled trial

The Lancet Respiratory Medicine ◽

10.1016/s2213-2600(13)70200-5 ◽

2014 ◽

Vol 2 (1) ◽

pp. 63-72 ◽

Author(s):

Henrik Watz ◽

Helen Barnacle ◽

Benjamin F Hartley ◽

Robert Chan

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Controlled Trial ◽

Chronic Obstructive ◽

Efficacy And Safety ◽

Double Blind ◽

Obstructive Pulmonary Disease ◽

Double Blind Placebo ◽

P38 Mapk Inhibitor ◽

Download Full-text

A Comparison of Tiotropium 18µg, Once Daily and Ipratropium 40µg, 4 Times Daily in a Double-Blind, Double-Dummy, Efficacy and Safety Study in Adults with Chronic Obstructive Pulmonary Disease

Tuberculosis and Respiratory Diseases ◽

10.4046/trd.2005.58.5.498 ◽

2005 ◽

Vol 58 (5) ◽

pp. 498 ◽

Author(s):

Seung Joon Kim ◽

Myung Sook Kim ◽

Sang Haak Lee ◽

Young Kyoon Kim ◽

Hwa Sik Moon ◽

...

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Chronic Obstructive ◽

Efficacy And Safety ◽

Safety Study ◽

Double Blind ◽

Obstructive Pulmonary Disease ◽

Download Full-text

Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial

The Lancet Respiratory Medicine ◽

10.1016/s2213-2600(13)70286-8 ◽

2014 ◽

Vol 2 (3) ◽

pp. 187-194 ◽

Author(s):

Jin-Ping Zheng ◽

Fu-Qiang Wen ◽

Chun-Xue Bai ◽

Huan-Ying Wan ◽

Jian Kang ◽

...

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Controlled Trial ◽

Chronic Obstructive ◽

Double Blind ◽

Obstructive Pulmonary Disease ◽

Double Blind Placebo

Download Full-text

Effects of theophylline in chronic obstructive pulmonary disease petients during high-dose bronchodilator inhalation therapy.

Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics ◽

10.3999/jscpt.26.407 ◽

1995 ◽

Vol 26 (1) ◽

pp. 407-408

Author(s):

KAZUO KAWAKATSU

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Inhalation Therapy ◽

Chronic Obstructive ◽

High Dose ◽

Obstructive Pulmonary Disease

Download Full-text

Effects of a combination of umeclidinium/vilanterol on exercise endurance in patients with chronic obstructive pulmonary disease: two randomized, double-blind clinical trials

Therapeutic Advances in Respiratory Disease ◽

10.1177/1753465814559209 ◽

2014 ◽

Vol 8 (6) ◽

pp. 169-181 ◽

Author(s):

François Maltais ◽

Sally Singh ◽

Alison C. Donald ◽

Glenn Crater ◽

Alison Church ◽

...

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Clinical Trials ◽

Pulmonary Disease ◽

Chronic Obstructive ◽

Double Blind ◽

Obstructive Pulmonary Disease ◽

Exercise Endurance

Download Full-text